Document is current
Any future updates will be listed below
-
Authors
Knowles, Juliet K. https://orcid.org/0000-0002-9214-2991
Xu, Haojun
Soane, Caroline
Batra, Ankita
Saucedo, Tristan
Frost, Eleanor
Tam, Lydia T. https://orcid.org/0000-0002-9900-3249
Fraga, Danielle
Ni, Lijun
Villar, Katlin
Talmi, Sydney https://orcid.org/0000-0002-9711-5650
Huguenard, John R. https://orcid.org/0000-0002-6950-1191
Monje, Michelle https://orcid.org/0000-0002-3547-237X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K08NS119800, R01NS034774, R01NS092597, DP1NS111132)
Child Neurology Foundation (NA)
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (NA)
Cancer Research UK (NA)
- License Information
-
More Information
Article History
Received: 10 May 2021
Accepted: 14 March 2022
First Online: 2 May 2022
Competing interests
: M.M. is on the Scientific Advisory Board of Cygnal Therapeutics. The authors declare no other competing interests.
